Real-time enrollment status for this alpha-1 antitrypsin deficiency clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05897424 |
| Recruiting Status | Recruiting |
| Condition | Alpha-1 Antitrypsin Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 185 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Sanofi |
| Last Updated on CT.gov | October 24, 2025 (Oct 24, 2025) |
As of March 2, 2026: Clinical trial NCT05897424 is currently recruiting participants. This clinical trial study for alpha-1 antitrypsin deficiency is actively seeking new participants at 19 locations across the United States. The study is sponsored by Sanofi. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05897424 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05897424 was last updated Oct 24, 2025 (October 24, 2025). HelloStudys verifies this status automatically.